Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:56 AM
Ignite Modification Date:
2025-12-25 @ 3:56 AM
NCT ID:
NCT04188002
Eligibility Criteria:
Inclusion Criteria:
* ≥18 years of age
* primary language is English
* histologically confirmed stage 1-111A invasive breast cancer or stage 1-3 colorectal cancer
* between at least 6 months to 5 years since completion of all primary cancer treatments (e.g. surgery, radiation, chemotherapy with the exception of women on adjuvant Herceptin therapy)
* have access to the internet; have an email and/or cell phone (to accept text message reminders from the study).
Exclusion criteria:
Include women that may be pregnant and anyone that is/has:
* A history of another cancer (exception for non-melanoma skin cancers)
* Self-reported comorbidities that would preclude engaging in physical activity safely (e.g. functional limitations or symptomatic cardiovascular or pulmonary disease)
* Plans or scheduled for major surgery (including breast reconstruction) during the intervention time frame
* Any psychiatric illness that would make it difficult to participate in the study
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT04188002
Study Brief:
Protocol Section:
NCT04188002